Latest News
-

'Buzzilia' from the Huntington's Disease World Congress: day 4
#Buzzilia, day 4: Jeff and Ed's roundup of happenings from the closing day of the HD World Congress in Rio de Janeiro
-

'Buzzilia' from the Huntington's Disease World Congress: day 3
#Buzzilia, day 3: Jeff and Ed's roundup of happenings from the third day of the HD World Congress in Rio de Janeiro
-

'Buzzilia' from the Huntington's Disease World Congress: day 2
#Buzzilia, day 2: Jeff and Ed's roundup of happenings from the second day of the HD World Congress in Rio de Janeiro
-

'Buzzilia' from the Huntington's Disease World Congress: day 1
#Buzzilia, day 1: Jeff and Ed's roundup of happenings from the opening day of the HD World Congress in Rio de Janeiro
-

Coming soon from the 2013 Huntington's Disease World Congress: Buzzilia!
HDBuzz presents 'Buzzilia!', our reports from the 2013 HD World Congress in Rio de Janeiro, from Sun 15 September
-

Could muscle problems help explain movements in Huntington’s Disease patients?
Proper contraction of muscles is crucial for coordination; errors in this process might help explain movements in HD
-

The 2013 HDBuzz Prize for Young Science Writers
Announcing the 2013 HDBuzz Prize for Young Science Writers!
-

Does a 'rusty hinge' cause Huntington's disease?
Canadian scientists have found that the mutant huntingtin protein is less flexible than normal.
-

How long is too long? Rethinking the Huntington’s disease ‘gray area’
Does an ‘intermediate’ CAG repeat count in the Huntington’s disease gene cause brain changes?
-

Can sad mice help treat Huntington's disease?
What can we learn about depression symptoms in HD by studying mice – how do you know a mouse is even sad?
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Previously featured
-
June 2026: This Month in Huntington’s Disease Research
-
Precision Pruning with PROTACs: Selective Targeting of Toxic Huntingtin
-
Your DNA Shouldn’t Cost You Your Insurance: What HD Families Need to Know
-
The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130
-
First participant dosed in pioneering neural stem cell trial for Huntington’s disease
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
